Floatz logo

Human Chorionic Gonadotropin

Uterine Corpus Leiomyoma

Lebanese Universityprotein_peptidePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Uterine Corpus Leiomyoma cohort.

Asset / SponsorPhaseRating
Rocuronium Ion
Stony Brook University
Phase 4BB
Marcaine
University of California, Irvine
Phase 3B
Cyclobenzaprine
Christiana Care Health Services
Phase 4B
Indocyanine Green
Chen Chunlin
Early Phase 1CC
Ramifentanyl
Chosun University Hospital
N/AD
Desflurane
Chosun University Hospital
N/AD
lfa102
Novartis Pharmaceuticals
Phase 1NR

Same molecule, other indications

Human Chorionic Gonadotropin is also rated in:

polycystic ovary syndromeActive
BBB
Indicative · Phase 4
79 / 100
View asset →
infertility disorderDormant
BBB
Indicative · Phase 4
78 / 100
View asset →
anovulationDormant
BB
Indicative · Phase 3
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →